The Role of Retinal Progenitor microRNAs for Late-stage Progenitor Cell State and Muller Glia Reprogramming
The Role of Retinal Progenitor microRNAs for Late-stage Progenitor Cell State and Muller Glia Reprogramming
批准号:
10570874
负责人:
Stefanie G Wohl
金额:
$40.5万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-01 至 2027-02-28
关键词:
3&apos Untranslated Regions3-DimensionalAddressAge related macular degenerationArchitectureBindingBiological AssayBlindnessCell CycleCell ProliferationCell ReprogrammingCell physiologyCellsCyclin D1DataDevelopmentDiseaseDisease ProgressionElectrophysiology (science)EnzymesFishesGene ExpressionGene Expression ProfileGenerationsGenesGoalsIn VitroIonsLeadMalignant NeoplasmsMeasuresMessenger RNAMicroRNAsMolecularMonitorMorphologyMuller&aposs cellMusNatural regenerationNeural RetinaNeurogliaNeuronsOrganismPathologicPhotoreceptorsPlayPostdoctoral FellowProliferatingPropertyRegenerative MedicineRegulationReporterResourcesRetinaRetinal DegenerationRetinal DiseasesRetinitis PigmentosaRodRoleSourceSupplementationTestingTherapeutic AgentsTherapeutic UsesTissuesValidationVisual impairmentVisualizationWorkantagonistbiomarker identificationcandidate selectioncell behaviorcell fate specificationcell replacement therapycell typeexperimental studyin vivoinnovationoverexpressionpatch clamppostnatalpostnatal developmentpreservationpreventprogramsrepairedrestorationretinal neuronretinal progenitor cellretinal regenerationretinal rodsretinogenesissensorsight restorationsingle-cell RNA sequencingstem cell therapystem cellstherapy developmenttooltranscription factortransplantation therapy
中文摘要
项目总结
我们的长期目标是通过干扰疾病进展或发育细胞来预防失明。
恢复视力的替代疗法。我们认为microRNAs(MiRNAs)是一种非常强大和创新的
工具来实现这一点,但我们首先需要确定视网膜细胞命运指定所需的miRNAs集
以及发育中的视网膜的正常细胞功能。这些miRNAs可能是潜在的治疗剂
不仅恢复与视网膜疾病的发生有关的失衡,而且还诱导特定的细胞命运
Müler glia(MG)重新编程。因此,我们建议研究视网膜前体细胞(RPC)的作用-
用于晚期RPC状态和功能以及MG重新编程的miRNAs,目标1:确定特定的miRNAs
出生后早期发育所必需的,此时杆状感光细胞(PR)、双极细胞(BCS)和MG
已生成。目的2:测试miRNAs将MG重新编程为功能性视网膜神经元,重点放在BCS和视杆细胞上
公共关系我们建议使用一种不能在其RPC中产生miRNAs的小鼠系来更好地理解
MiRNAs在视网膜发育和疾病中的作用。我们将分析组织和细胞关于
形态和功能变化,并确定哪些miRNAs负责细胞内的变化
行为。如果我们发现某些细胞类型在没有miRNAs的情况下不能正常形成,这可能意味着特定的
MiRNAs是该细胞类型正常发育所必需的。救援实验将显示是否受到干扰
通过补充miRNA可以恢复组织,这意味着潜在的治疗用途。这些miRNA
也可能是新的、额外的重新编程因子,以从干细胞或MG再生特定类型的细胞。我的
先前的工作表明,miRNAs可以将MG重新编程为类似于BCS的神经元样细胞。然而,
这些重新编程的神经元是否具有功能,以及是否产生了其他神经元,目前尚不清楚。
为了解决这些问题,我们将从报告小鼠重新编程原始MG,以可视化MG的转换
进入RPC和神经元样细胞,使用膜片钳测量离子电流,并分析它们的基因表达。
成功将MG转化为功能神经元的miRNA候选分子将随后在3D中进行测试
器官培养(生物体外完整的视网膜)。外植体将用miRNAs处理并进行评估
关于细胞的增殖和适当的分化能力。可诱发MG的miRNA候选基因
体外重编程将被用于体内重编程方法。揭示潜在的机制
和真正的miRNAs目标,我们将使用目标预测和目标验证工具来缩小范围并进行测试
通过传感器(体外证明miRNA:信使核糖核酸的预测)和抢救实验选择候选者。这部作品
通过将分子和细胞分析与功能测试相结合,提供对miRNAs的全面研究,
在体外、体外和体内,将揭示(1)正常视网膜发育和细胞所需的一组miRNAs
晚出生视网膜神经元的命运指定以及(2)可以将MG重新编程为功能性的一组miRNAs
神经元。
英文摘要
PROJECT SUMMARY
Our long-term goal is to prevent blindness, either by interfering with disease progression or by developing cell
replacement therapies to restore vision. We believe that microRNAs (miRNAs) are a very powerful and innovative
tool to accomplish this, but we first need to identify the set of miRNAs required for retinal cell fate specification
and proper cell function in the developing retina. These miRNAs might represent potential therapeutic agents to
not only restore imbalances that occur with the onset of retinal disorders, but also to induce specific cell fates for
Müller glia (MG) reprogramming. We therefore propose to investigate the role of retinal progenitor cell (RPC)-
miRNAs for late-stage RPC state and function and MG reprogramming by Aim 1: identifying the specific miRNAs
required in early postnatal development, when rod photoreceptors (PR), bipolar cells (BCs), and MG are
generated. Aim 2: testing miRNAs to reprogram MG into functional retinal neurons with focus on BCs and rod
PR. We propose to use a mouse line that will not be able to produce miRNAs in their RPCs to better understand
the function of miRNAs in retinal development and diseases. We will analyze tissue and cells with regard to
morphological and functional alterations and determine which miRNAs are responsible for changes in cellular
behavior. If we discover certain cell types that do not form properly without miRNAs, this could mean that specific
miRNAs are required for proper development of that cell type. Rescue experiments will show whether disturbed
tissue can be restored by miRNA supplementation and would imply potential therapeutic use. These miRNAs
might also be new, additional reprogramming factors to regenerate specific cell types from stem cells or MG. My
previous work has shown that miRNAs can reprogram MG into neuronal-like cells similar to BCs. However,
whether these reprogrammed neurons are functional, and whether other neurons are generated, is still unknown.
To address these questions, we will reprogram primary MG from reporter mice to visualize the conversion of MG
into RPCs and neuronal-like cells, use patch clamp to measure ion currents, and profile their gene expression.
miRNA candidates that successfully converted MG into functional neurons will be tested subsequently in 3D
organotypic cultures (intact retinas outside the organism). Explants will be treated with miRNAs and evaluated
with regard to cell proliferation and proper differentiation capability. miRNA candidates that can induce MG
reprogramming ex vivo will be utilized for in vivo reprogramming approaches. To reveal underlying mechanisms
and true miRNAs targets, we will use target prediction and target validation tools to narrow down and test
selected candidates via sensors (in vitro proof of miRNA:mRNA prediction) and rescue experiments. This work
provides a comprehensive study of miRNAs by combining molecular and cellular analyses with functional testing,
in vitro, ex vivo and in vivo and will reveal (1) the set miRNAs required for proper retinal development and cell
fate specification of late-born retinal neurons and (2) the set of miRNAs that can reprogram MG into functional
neurons.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Retinal Progenitor microRNAs for Late-stage Progenitor Cell State and Muller Glia Reprogramming
-
批准号:10366875
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2022
-
负责人:Stefanie G Wohl
-
依托单位:
海外基金